NovoCure Limited (NVCR)
NASDAQ: NVCR · Real-Time Price · USD
10.55
-0.29 (-2.68%)
At close: Apr 2, 2026, 4:00 PM EDT
10.51
-0.04 (-0.38%)
After-hours: Apr 2, 2026, 7:28 PM EDT
NovoCure Employees
NovoCure had 1,605 employees as of December 31, 2025. The number of employees increased by 117 or 7.86% compared to the previous year.
Employees
1,605
Change (1Y)
117
Growth (1Y)
7.86%
Revenue / Employee
$408,320
Profits / Employee
-$84,877
Market Cap
1.20B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 1,605 | 117 | 7.86% |
| Dec 31, 2024 | 1,488 | 35 | 2.41% |
| Dec 31, 2023 | 1,453 | 133 | 10.08% |
| Dec 31, 2022 | 1,320 | 153 | 13.11% |
| Dec 31, 2021 | 1,167 | 144 | 14.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| AdaptHealth | 10,900 |
| Enovis | 7,802 |
| QuidelOrtho | 6,500 |
| UFP Technologies | 4,846 |
| CONMED | 3,900 |
| Tandem Diabetes Care | 2,500 |
| Inspire Medical Systems | 1,333 |
| PROCEPT BioRobotics | 888 |
NVCR News
- 2 days ago - Novocure to Report First Quarter 2026 Financial Results - Business Wire
- 8 days ago - NovoCure Tumor Treating Fields Shows Improved Outcomes In Tough Pancreatic Cancer - Benzinga
- 8 days ago - Novocure Announces Positive Topline Results from Phase 2 PANOVA-4 Clinical Trial of Tumor Treating Fields (TTFields) Therapy for Metastatic Pancreatic Cancer - Business Wire
- 4 weeks ago - Novocure Announces Optune Lua® Receives Reimbursement Approval in Japan for the Treatment of Non-Small Cell Lung Cancer - Business Wire
- 4 weeks ago - Novocure to Participate in 2026 Leerink Global Healthcare Conference - Business Wire
- 5 weeks ago - NovoCure Limited (NVCR) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Novocure Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Company Update - Business Wire
- 5 weeks ago - Tumor Treating Fields (TTFields) Therapy to be Covered for Patients with Newly Diagnosed Glioblastoma Through British Columbia Cancer (BC Cancer) - Business Wire